Iterum Therapeutics plc - Ordinary Share (NQ: ITRM )
1.340
-0.040
(-2.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
All News about Iterum Therapeutics plc - Ordinary Share

Lawsuits Filed Against ITRM, PHG and ANVS - Jakubowitz Law Pursues Shareholders Claims
September 13, 2021
From Jakubowitz Law
Via AccessWire

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLCT, ITRM and PHG
September 13, 2021
From The Gross Law Firm
Via AccessWire
Topics
Lawsuit




LAWSUITS FILED AGAINST QFIN, ARDX and ITRM - Jakubowitz Law Pursues Shareholders Claims
September 09, 2021
From Jakubowitz Law
Via AccessWire


The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, ITRM and KPLT
September 09, 2021
From The Gross Law Firm
Via AccessWire


SHAREHOLDER ALERT: ATVI ITRM ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
September 06, 2021
Via AccessWire
Topics
Fraud
Exposures
Legal


SHAREHOLDER ALERT: ITRM SESN SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
September 03, 2021
Via AccessWire
Topics
Fraud
Exposures
Legal

LAWSUITS FILED AGAINST ITRM, YALA and VIEW - Jakubowitz Law Pursues Shareholders Claims
September 02, 2021
From Jakubowitz Law
Via AccessWire












Via AccessWire
Topics
Lawsuit




SHAREHOLDER ALERT: SRAC QFIN ITRM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
August 24, 2021
Via AccessWire
Topics
Fraud
Exposures
Legal
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free